GlobalData Plc: Big Data Crucial for Business Strategy Across the Pharma Value Chain – GlobeNewswire

GlobalData Plc: Big Data Crucial for Business Strategy Across the Pharma Value Chain – GlobeNewswire

| Source: GlobalData Plc GlobalData Plc
London, UNITED KINGDOM
LONDON, May 18, 2022 (GLOBE NEWSWIRE) — The healthcare and pharmaceutical industry generates data in abundance in the form of physician notes, pathology reports, EHR, patient registries, genomics, clinical trials, spontaneous adverse drug reaction reports, social media, wearable devices, and many other sources that are collected digitally. The datasets in question are huge in both size and complexity, rendering traditional data management techniques inefficient for processing. When properly analyzed, big data can be very powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, the optimization of manufacturing processes, the management of supply chains, and the creation of innovative sales and marketing strategies.

The Big Data in Pharmaceuticals – Thematic Research report offered by GlobalData Plc assesses how big data analytics, combined with other emerging technologies, can be used across the pharma value chain. It provides an overview of the current landscape, including healthcare, technology, regulatory, and macroeconomic trends, as well as key players, while also highlighting opportunities for the use of big data analytics in the future. Moreover, the report provides an analysis of big data-related deals, jobs, and social media activity, highlighting the impact of the COVID-19 pandemic, where relevant.

For more insights on the report, download a free report sample
Key Healthcare Trends Impacting the Big Data Theme in Pharmaceuticals
Key Technology Trends Impacting the Big Data Theme in Pharmaceuticals
Key Regulatory Trends Impacting the Big Data Theme in Pharmaceuticals
Key Macroeconomic Trends Impacting the Big Data Theme in Pharmaceuticals
For more insights on trends impacting the big data theme in the pharmaceuticals industry, download a free report sample
Value Chains of Big Data in the Pharmaceuticals Market
To know more about the value chains of big data in the pharmaceuticals market, download a free report sample
Leading Public Big Data Vendors
Leading Private Big Data Vendors
Leading Big Data Adopters in the Pharmaceuticals Industry
To know more about vendors and adopters of big data in the pharmaceuticals market, download a free report sample
Big Data in Pharmaceuticals Market Overview
Big Data in Pharmaceuticals Market Report Scope
Reasons to Buy
FAQs
What was the global data and analytics market size in the pharmaceutical sector in 2020?
The global data and analytics market in the pharmaceutical sector was valued at $1.4 billion in 2020.
What are the key trends impacting the big data theme in the pharmaceuticals sector?
The key trends impacting the big data theme in the pharmaceuticals sector are healthcare trends, technological trends, regulatory trends, and macroeconomic trends.
What are the big data value chains in the pharmaceuticals market?
The big data value chains in the pharmaceuticals market are big data generation, big data management, and big data product development.
Who are the leading public big data vendors in the pharmaceuticals market?
The public big data vendors in the pharmaceuticals market are Amazon, International Business Machines, Microsoft, Oracle, and SAP SE.
Who are the leading private big data vendors in the pharmaceuticals market?
The private big data vendors in the pharmaceuticals market are Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, Medidata Solutions, Owkin, Recursion Pharmaceuticals, Sensyne Health, Syapse, Syneos Health, TriNetX, and Unlearn.AI.
Who are the leading adopters of big data in the pharmaceuticals market?
The key adopters of big data in the pharmaceuticals market are Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co, Moderna, Novartis, Pfizer, Roche, Sanofi, Takeda, and Tevaz.
Related reports
About us
GlobalData is a leading provider of data, analytics, and insights on the world’s largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData’s mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professionals within corporations, financial institutions, professional services, and government agencies.
Media Contacts
GlobalData
Mark Jephcott
Head of PR EMEA
mark.jephcott@globaldata.com
cc: pr@globaldata.com
+44 (0)207 936 6400

source


Leave a Reply

Your email address will not be published.